National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 348920

Case Details

VAERS ID: 348920 (history)  
Form: Version 1.0  
Age: 16.0  
Gender: Female  
Location: Florida  
Vaccinated:2009-05-18
Onset:2009-05-28
   Days after vaccination:10
Submitted: 2009-06-10
   Days after onset:13
Entered: 2009-06-11
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0315Y / 2 RA / IM

Administered by: Other       Purchased by: Other
Symptoms: Antinuclear antibody, Biopsy bone marrow, Blood product transfusion, Complement factor C3, Complement factor C4, Full blood count, Idiopathic thrombocytopenic purpura, Metabolic function test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: DEPO-PROVERA
Current Illness:
Preexisting Conditions: None 6/22/09-records received- PMH Depo Provera.
Allergies:
Diagnostic Lab Data: Unknown 6/22/09-records received-Two weeks prior platelet count of 26. Rheumatology labs negative.
CDC Split Type: WAES0906USA01158

Write-up: Information has been received from a physician concerning a 16-year-old female patient with no medical history who was vaccinated with the second dose of GARDASIL. Concomitant therapy included Depo-Provera. A week or two after the second dose of GARDASIL the patient developed idiopathic thrombocytopenic purpura and was admitted to hospital and given intravenous immune globulin (IVIG) 2 doses. The following lab diagnostics studies was performed: Complete blood count, Comprehensive Metabolic Panel, Antinuclear Antibody Test, serum complement C3/C4 ratio, Immunoglobulin A, Bone marrow biopsy. The patient has been discharged. The patient''s idiopathic thrombocytopenic purpura was considered to be disabling and an other important medical event. The patient had not been recovered. Additional information has been requested. 6/22/09-records received for DOS 5/28-5/30/09- DC DX: ITP status post 2 doses of IVIG with slight improvement of platelet count. Presented with newly diagnosed ITP with mild bruising. ICD-9 287.31.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=348920


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166